KEP Q4 2025 Earnings EPS Misses Estimates Amid Cost Pressures Stock Slips HLX Q1 2026 Earnings Narrow Loss Wider Than Expected Stock Slides SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise CSRS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges THO Q1 2026 Earnings Massive EPS Beat Drives Positive Market Response CTO Q1 2026 Earnings Massive EPS Surprise Highlights Operational Efficiency Amid Mixed Market Signals